SCHEMBL29935680

SCHEMBL29935680

CN1C=COc2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
CRHBP P24387 2/20 0.33
CRHR2 Q13324 2/20 0.33
HTT P42858 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.32
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32
P2RX4 Q99571 5/20 0.32
MAOA P21397 1/20 0.31
P2RX1 P51575 1/20 0.31
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ACHE P22303 1/20 0.30
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14114311 1.00 SMN1; SMN2 (0.33) SMN1; SMN2LMNACRHBPCRHR2HTT
SCHEMBL9130836 0.74 LMNA (0.33) SMN1; SMN2LMNACRHBPCRHR2HTT
SCHEMBL11119032 0.74 GAA (0.32) LMNAKDM4E
SCHEMBL19337001 0.74 KDM4E (0.35) SMN1; SMN2LMNACRHBPCRHR2HTT
SCHEMBL19699832 0.74 P2RX4 (0.35) SMN1; SMN2LMNACRHBPCRHR2HTT
SCHEMBL656129 0.72 MAPT (0.35) SMN1; SMN2LMNASLC6A2SLC6A4MAPT
SCHEMBL8999590 0.72 CYP3A4 (0.34) LMNAMAPTNPSR1
SCHEMBL30933613 0.72 ALDH1A1 (0.36) SMN1; SMN2HTTMAPTALDH1A1ACHE
SCHEMBL6420871 0.71 MEN1 (0.39) SMN1; SMN2LMNAHTTP2RX4P2RX1
SCHEMBL30534441 0.71 BCHE (0.34) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP SMN1; SMN2 3418/4885LMNA 1308/4885CRHBP 1407/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH SMN1; SMN2 3345/4885LMNA 1988/4885CRHBP 800/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP SMN1; SMN2 3418/4885LMNA 1308/4885CRHBP 1407/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP SMN1; SMN2 3418/4885LMNA 1308/4885CRHBP 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.